Acumen Hypotension Prediction Index (HPI) Feature Software vs AHI System
AI Verdict
Choose Acumen Hypotension Prediction Index (HPI) Feature Software if…
Choose Acumen Hypotension Prediction Index (HPI) software if your primary goal is the proactive prediction and management of hypotensive events, particularly in critical care or surgical settings where precise hemodynamic insights are crucial. This tool is ideal when you need to predict hypotension up to 15 minutes in advance using blood pressure waveform analysis, allowing for targeted interventions based on detailed parameters like preload, afterload, and contractility.
View Acumen Hypotension Prediction Index (HPI) Feature Software →Choose AHI System if…
Choose the AHI System if your priority is the very early detection of general hemodynamic instability, hours before changes in standard vital signs become apparent, across a broader patient population. This software-only solution leverages continuous ECG signals to provide real-time predictive analytics, making it suitable for environments seeking to reduce nursing burden and improve patient prioritization by integrating seamlessly with existing monitoring infrastructure.
View AHI System →When considering AI tools for predicting hemodynamic instability, physicians can choose between Edwards Lifesciences’ Acumen HPI Feature Software and Fifth Eye’s AHI System. Acumen HPI excels at predicting hypotensive events up to 15 minutes in advance, utilizing machine learning on blood pressure waveforms to provide a quantitative HPI score and insights into preload, afterload, and contractility. It is integrated into the Edwards Lifesciences HemoSphere platform and is best suited for settings where invasive or non-invasive blood pressure monitoring is already a standard, such as in anesthesiology or critical care, allowing for proactive management of impending hypotension.
In contrast, Fifth Eye’s AHI System offers real-time predictive analytics for hemodynamic instability, detecting patient deterioration hours before changes in vital signs by analyzing continuous Lead II ECG signals. This software-only device integrates with existing hospital IT infrastructure and patient monitoring platforms, making it a flexible option for broader deployment across critical care, emergency medicine, and hospital medicine. The key practical difference lies in their data input and prediction window: Acumen HPI focuses on blood pressure dynamics for short-term hypotension prediction, while AHI leverages ECG signals for earlier, broader detection of hemodynamic instability.
Physicians prioritizing precise, short-term prediction and detailed hemodynamic parameter insights, particularly in perioperative or intensive care settings with existing Edwards Lifes Lifesciences monitoring, would find Acumen HPI more aligned with their needs. Conversely, those seeking an earlier, more generalized warning of hemodynamic instability across a wider range of hospital settings, utilizing readily available ECG data and a software-only deployment, would likely prefer Fifth Eye’s AHI System for its ability to provide hours of lead time before vital sign changes.
Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | Acumen Hypotension Prediction Index (HPI) Feature Software | AHI System |
|---|---|---|
| Pricing | Contact vendor | Contact for pricing |
| Deployment | Integrated into Edwards Lifesciences HemoSphere advanced monitoring platform. | Software-only device, integrates with existing hospital IT infrastructure and patient monitoring platforms. |
| FDA Status | 1 AI-estimated | Yes AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
AHI SystemTool B (AHI System) is a software-only device that integrates with existing hospital IT infrastructure and patient monitoring platforms, making it highly adaptable and less disruptive to current workflows. Its use of widely available ECG signals and explicit claims of reducing nursing burden and providing intuitive, color-coded risk indicators suggest a superior focus on streamlined usability and efficiency for clinicians.
Clinical Value
AHI SystemTool B (AHI System) demonstrates superior clinical value by providing an average of over 26 hours of advanced warning before a Rapid Response Team (RRT) event, significantly outperforming traditional vital signs. This extended lead time for detecting broader hemodynamic instability offers a much greater window for proactive and potentially preventative interventions compared to Tool A's (Acumen HPI) prediction of hypotension up to 15 minutes before an event.
Pricing & Value
TieBoth Tool A (Acumen HPI) and Tool B (AHI System) have opaque pricing models, requiring direct contact with the vendor for information. Without publicly available pricing details or transparent licensing structures, it is impossible to conduct a head-to-head comparison of their value propositions.
Enterprise Readiness
TieBoth tools are FDA-cleared, HIPAA compliant, and offer BAAs, indicating a strong foundation for enterprise deployment. While Tool A (Acumen HPI) benefits from Edwards Lifesciences' established presence and infrastructure, Tool B (AHI System) offers greater deployment flexibility as a software-only solution that integrates with multiple existing hospital monitoring platforms, making it adaptable to diverse IT environments.
Innovation
AHI SystemTool B (AHI System) demonstrates greater innovation by utilizing continuous Lead II ECG signals to predict broader hemodynamic instability and RRT events hours in advance. This novel, non-invasive approach, with its significantly extended lead time compared to Tool A's (Acumen HPI) blood pressure waveform analysis for 15-minute hypotension prediction, represents a more impactful technological advancement in early patient deterioration detection.
Support & Docs
Acumen Hypotension Prediction Index (HPI) Feature SoftwareTool A (Acumen HPI), offered by Edwards Lifesciences, provides clearly documented 24/7 technical support channels across multiple regions and readily available user guides/operator's manuals. While Tool B (AHI System) mentions user manual content in its FDA documentation and may offer support through partnerships, direct and comprehensive support information is not as explicitly detailed as for Tool A.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | Acumen Hypotension Prediction Index (HPI) Feature Software | AHI System |
|---|---|---|
| Name | Acumen Hypotension Prediction Index (HPI) Feature Software | AHI System |
| Company | Edwards Lifesciences | Fifth Eye |
| Description | Edwards Lifesciences' Acumen Hypotension Prediction Index (HPI) software is a predictive monitoring tool that uses machine learning to detect and alert clinicians to the likelihood of a hypotensive event before it occurs, aiding in proactive hemodynamic management and improving patient outcomes. | Fifth Eye's AHI System is an FDA-cleared AI-powered software that provides real-time predictive analytics for hemodynamic instability, detecting patient deterioration hours before vital signs. It uses continuous ECG signals to enhance clinical decision-making and optimize hospital resources. |
| Key Predictive Input | Machine learning algorithms for predictive analysis of blood pressure waveforms | Utilizes continuous Lead II ECG signals |
| Prediction Timeframe | Predicts hypotension up to 15 minutes before an event | Provides early warning (hours ahead of vital signs) |
Videos
Demos, reviews, and walkthroughs featuring Acumen Hypotension Prediction Index (HPI) Feature Software and AHI System.